Abstract:Background: To study the expression of the RIZ1 (Retinoblastoma protein-interacting zinc-finger gene 1) gene and investigate the promoter region methylation status of RIZ1 gene in the human esophageal squamous cell carcinoma (ESCC) cell lines of KYSE150, KYSE510, TE13, EC9706, CaEs17, and EC109. To investigate the influence of DNMT (DNA methyltransferase) 5-aza-CdR(5-aza-2'-deoxycytidine) on the transcription of the RIZ1 gene in one cell line whose RIZ1 gene promoter region methylation was detected, and to investigate its influence on the cell proliferation.Methods: Real-time PCR (Real-time quantitative PCR) and an immunohistochemistry technique was used to get the expression of RIZ1 in specimens from 6 human ESCC cell lines and 28 ESCC patients (tumor tissues and adjacent non-cancerous tissues). MSP (Methylation-specific PCR) was used to investigate the promoter region methylation status of the RIZ1 gene in the 6 ESCC cell lines. One cell line, whose RIZ1 gene promoter region methy-lation was detected, was chosen for the next studies in which it was treated it by with 5-aza-CdR. Real-time PCR was used to investigate its influence on the transcription of RIZ1 gene and MTT (methyl thiazolyl tetrazolium) was used to detect if 5-aza-CdR inhibits the proliferation of the cell line.Results: In the 28 ESCC patient samples, RIZ1 expression was significantly lower in the tumor tissues than that in their adjacent non-cancerous tissues (p<0.05). Consistently, immunohistochemistry analyses of RIZ1 protein expression showed that in the ESCC tissues RIZ1 protein expression was also significantly lower than in the adjacent tissues. In the human ESCC tissues the rate of expression accounts for 0% (0/12), and in the adjacent non-cancerous tissues the rate of expression was 66.7% (8/12), the correlation was highly significant (chi(2) = 12.000, p<0.05). Promoter methylation of the RIZ1 gene was detected in TE13, CaEs17, EC109. The cell line TE13 was chosen for the next studies. The expression of RIZ1 mRNA in TE-13 was up-regulated after having been treated with 5-aza-CdR. 5-aza-CdR inhibited cell proliferation of TE-13 in a time and concentration-dependent manner.Conclusions: Promoter methylation may play an important role in the epigenetic silencing of RIZ1 gene expression. Methylation of the RIZ1 promoter and loss of RIZ1 expression in human ESCC are independent biomarkers. Their determination may offer guidance for selecting appropriate diagnoses and treatments. RIZ1 may be a potential tumor suppressor in human ESCC. (Clin. Lab. 2012;58:41-51)

Epigenetic Silencing of ZNF132 Mediated by Methylation-Sensitive Sp1 Binding Promotes Cancer Progression in Esophageal Squamous Cell Carcinoma

Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells

Hypermethylation-modulated Down-Regulation of CDH1 Expression Contributes to the Progression of Esophageal Cancer.

H3K27me3 Inactivates SFRP1 to Promote Cell Proliferation Via Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma

Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma

Expression and DNA Methylation Status of Long Non-coding RNA ZNF667-AS1 in Esophageal Squamous Cell Carcinoma Tissues

Dna Methylation Status Of Pax1 And Znf582 In Esophageal Squamous Cell Carcinoma

High methylation of the same promoter of lncRNA ZNF582-AS1/ ZNF582 promotes malignant progression of esophageal cancer

Role of ZIC1 Methylation in Hepatocellular Carcinoma and Its Clinical Significance

Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma

Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma

Methylation of ZNF331 Promotes Cell Invasion and Migration in Human Esophageal Cancer

Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma

Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling

DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.

Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.

Decreased Expression of Retinoblastoma Protein-Interacting Zinc-Finger Gene 1 in Human Esophageal Squamous Cell Cancer by DNA Methylation.

19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer

The Novel 19q13 KRAB Zinc-Finger Tumour Suppressor ZNF382 is Frequently Methylated in Oesophageal Squamous Cell Carcinoma and Antagonises Wnt/β-catenin Signalling

Targeted Bisulfite Sequencing Identified a Panel of DNA Methylation-Based Biomarkers for Esophageal Squamous Cell Carcinoma (ESCC)

Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma